NZ180552A - Pharmaceutical preparation containing a rigid macrom-orphological structure and a carbonxylic polymer or a salt there of - Google Patents

Pharmaceutical preparation containing a rigid macrom-orphological structure and a carbonxylic polymer or a salt there of

Info

Publication number
NZ180552A
NZ180552A NZ180552A NZ18055276A NZ180552A NZ 180552 A NZ180552 A NZ 180552A NZ 180552 A NZ180552 A NZ 180552A NZ 18055276 A NZ18055276 A NZ 18055276A NZ 180552 A NZ180552 A NZ 180552A
Authority
NZ
New Zealand
Prior art keywords
orphological
carbonxylic
macrom
rigid
salt
Prior art date
Application number
NZ180552A
Other languages
English (en)
Inventor
C Appelgren
J Sjogren
C Bogentoft
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of NZ180552A publication Critical patent/NZ180552A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
NZ180552A 1975-04-09 1976-04-08 Pharmaceutical preparation containing a rigid macrom-orphological structure and a carbonxylic polymer or a salt there of NZ180552A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7504049A SE7504049L (sv) 1975-04-09 1975-04-09 Colonpreparation

Publications (1)

Publication Number Publication Date
NZ180552A true NZ180552A (en) 1978-07-28

Family

ID=20324216

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ180552A NZ180552A (en) 1975-04-09 1976-04-08 Pharmaceutical preparation containing a rigid macrom-orphological structure and a carbonxylic polymer or a salt there of

Country Status (12)

Country Link
BE (1) BE840552A (xx)
DE (1) DE2614296A1 (xx)
DK (1) DK153376A (xx)
FI (1) FI56772C (xx)
FR (1) FR2306710A1 (xx)
GB (1) GB1538123A (xx)
IE (1) IE42793B1 (xx)
LU (1) LU74732A1 (xx)
NL (1) NL7603600A (xx)
NO (1) NO761101L (xx)
NZ (1) NZ180552A (xx)
SE (1) SE7504049L (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52139715A (en) * 1976-05-14 1977-11-21 Nippon Kayaku Co Ltd Coated granules of alkali polyacrylate
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
US4444761A (en) * 1981-05-04 1984-04-24 Syntex (U.S.A.) Inc. Cellulose/carboxymethyl cellulose mixtures useful for controlling fecal output, and methods employing them
US4461759A (en) * 1983-01-03 1984-07-24 Verex Laboratories, Inc. Constant release rate solid oral dosage formulations of veropamil
US4522804A (en) * 1983-01-03 1985-06-11 Verex Laboratories, Inc. Constant release rate solid oral dosage formulations of propranolol
US4521401A (en) * 1983-01-03 1985-06-04 Verex Laboratories, Inc. Constant release rate solid oral dosage formulations of quinidine
EP0273209B1 (en) * 1986-12-30 1992-01-15 American Cyanamid Company Composition of matter containing polycarbophil
GB8817015D0 (en) * 1988-07-16 1988-08-17 Reckitt & Colmann Prod Ltd Method of treatment
AU627775B2 (en) * 1988-09-20 1992-09-03 Glaxo Group Limited Pharmaceutical compositions
CA2082156A1 (en) * 1990-05-04 1991-11-05 Amnon Sintov Colonic drug delivery system
IL98087A (en) * 1990-05-04 1996-11-14 Perio Prod Ltd Preparation for dispensing drugs in the colon
DE9212938U1 (xx) * 1992-09-25 1992-11-26 Boehringer Ingelheim Gmbh, 6507 Ingelheim, De
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
WO2018191752A1 (en) 2017-04-14 2018-10-18 Gelesis Llc Compositions and methods for treating or preventing gut permeability-related disorders

Also Published As

Publication number Publication date
GB1538123A (en) 1979-01-10
DE2614296A1 (de) 1976-10-21
FR2306710A1 (fr) 1976-11-05
NO761101L (xx) 1976-10-12
DK153376A (da) 1976-10-10
FI760948A (xx) 1976-10-10
FI56772B (fi) 1979-12-31
SE7504049L (sv) 1976-10-10
IE42793L (en) 1976-10-09
IE42793B1 (en) 1980-10-22
FI56772C (fi) 1980-04-10
NL7603600A (nl) 1976-10-12
FR2306710B1 (xx) 1979-07-13
LU74732A1 (xx) 1977-02-04
BE840552A (fr) 1976-10-11

Similar Documents

Publication Publication Date Title
JPS529090A (en) Preparation of liquid polymer
PH12959A (en) Preparation of pharmaceutical unit dosage form
IL51660A (en) Hentriakontapetides being -endorphins their preparation and pharmaceutical compostions containing them
JPS51119095A (en) Preparation of inorganiccorganic plastics
EG14262A (en) Method of preparing pharmaceutical compoundes containing pyrethrinoides
IL50815A0 (en) New aminobenzoamides their preparation and pharmaceutical compositions containing them
JPS5328178A (en) Production of novel pyperidylindole derivatives * salt thereof and pharmaceutical composition
GB1520447A (en) Benzisoquinoline derivatives and pharmaceutical uses thereof
NZ180552A (en) Pharmaceutical preparation containing a rigid macrom-orphological structure and a carbonxylic polymer or a salt there of
IL50631A (en) 1-benzazolylalkyl-4-substituted-piperidines their preparation and pharmaceutical compositions containing them
JPS52107086A (en) Preparation of modified polymer and use thereof
JPS5315367A (en) 22benzilpyrrolidine* preparation thereof and medicine containing same
JPS51129477A (en) Preparation of solid polymer of monooalphaaolefin
GB1518764A (en) Isobutyramides their preparation and therapeutic composititions containing them
JPS5259161A (en) 1*44dihydroo2*66dimethyll44 phenyll3*55pyridineedicarbonic acid isobuthylmethyl preparation method and medicine thereof
JPS5257154A (en) Naphthalene derivatives * pharmaceutical composition and preparation thereof
JPS5379039A (en) Pharmaceutical preparation having heart protecting action
JPS52993A (en) Crosslinkagable polymer and preparation thereof
JPS5285126A (en) Novel phenetylamine derivatives* salts thereof and pharmaceutical composition
JPS527419A (en) Heterocolloidal deblicin containing medical composition and its preparation
JPS5295793A (en) Preparation of alphaapinene polymer
JPS51125330A (en) Novel acetamidoximes* preparation thereof and medicine
JPS523685A (en) Preparation of amino grouppcontaining polymer
JPS523060A (en) Paraachlorophenoxyisobutyric acid derivatives and preparation thereof
JPS52116437A (en) Preparation and use of pharmaceutical composition comprising novel compound